# Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte

> **NCT01627158** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 72 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Budesonide/formoterol Easyhaler
- **DRUG:** Symbicort Turbuhaler
- **DRUG:** Charcoal and Budesonide/formoterol Easyhaler
- **DRUG:** Charcoal and Symbicort Turbuhaler

## Key facts

- **NCT ID:** NCT01627158
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2012-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01627158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01627158, "Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01627158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*